Uluhan Sili

University of Novi Sad — RS

Medicine · Health Sciences

23h-index3.1kcitations100works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(38), SARS-CoV-2 and COVID-19 Research(25), Cytomegalovirus and herpesvirus research(14), COVID-19 and healthcare impacts(14), Virus-based gene therapy research(10)

Publications98 total

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry
American Journal of Hematology·2025Open Access
Sexual behaviours and sexually transmitted infections among MSM living with HIV followed at a university hospital in Istanbul, Turkey
International Journal of STD & AIDS·2025Open Access
MARMARA ÜNİVERSİTESİ PENDİK EĞİTİM VE ARAŞTIRMA HASTANESİ’NDE TAKİP EDİLEN HIV İLE YAŞAYAN BİREYLERİN KEMİK MİNERAL YOĞUNLUKLARININ DEĞERLENDİRİLMESİ
ANKEM Dergisi·2025Open Access
HIV İLE YAŞAYAN BİREYLERDE HLA-B*57:01 POZİTİFLİK DÜZEYİ
Kocatepe tıp dergisi.·2025Open Access
Prevalence and Associated Factors of Non-Alcoholic Fatty Liver Disease in People Living with HIV-1
Current HIV Research·2025
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy
UNC Libraries·2025Open Access
Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission
Turkish Journal of Internal Medicine·2024Open Access
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection·2024Open Access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Haematologica·2024· 7 citedOpen Access
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
EClinicalMedicine·2024· 29 citedOpen Access
The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study
Scientific Reports·2024· 3 citedOpen Access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection·2024· 9 citedOpen Access
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy
The Journal of Infectious Diseases·2024· 11 citedOpen Access
Investigation of syphilis seropositivity in adult individuals living with HIV followed at Marmara University Pendik Training and Research Hospital, 2024
Turkish Bulletin of Hygiene and Experimental Biology·2024· 1 citedOpen Access
Investigation of toxoplasma seropositivity in adult individuals infected with HIV followed at Marmara University Pendik Training and Research Hospital, 2024
Turkish Bulletin of Hygiene and Experimental Biology·2024Open Access
Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry
International Journal of Infectious Diseases·2023· 14 citedOpen Access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
Hematological Oncology·2023· 14 citedOpen Access
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
International Journal of Infectious Diseases·2023· 14 citedOpen Access
The Incidence and Factors Affecting the 28-day Hospital Admission Among Adult Ambulatory COVID-19 Patients
Klimik Dergisi/Klimik Journal·2023Open Access
Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic
Turkish Journal of Pharmaceutical Sciences·2023· 1 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Jon Salmanton‐García(15), Francesco Marchesi(13), Barbora Weinbergerová(13), Andreas Glenthøj(13), Iker Falces‐Romero(13), Cliona M. Rooney(12), Federico Itri(12), Jaap A. van Doesum(12), Ola Blennow(12), Stef Meers(12), Sonia Martín‐Pérez(12), Raúl Córdoba(11), Monia Marchetti(11), Francesca Farina(11), Chiara Cattaneo(11), Ozren Jakšić(11), Zdeněk Ráčil(11), Lucia Prezioso(11), Caterina Buquicchio(11), Martin Schönlein(11)